Vera Therapeutics
$40.86
48
+$0.36+0.89% Thursday 20:00
Statistics
Day High
41.45
Day Low
39.27
52W High
56.05
52W Low
18.53
Volume
695,785
Avg. Volume
1,154,450
Mkt Cap
2.92B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
7MayExpected
Expected EPS
-1.328378
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-599.23MNet Income
Analyst Ratings
$82.25Average Price Target
The highest estimate is 110.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy 88%
Hold 13%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow VERA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap148.78B
Abbvie
ABBV
Mkt Cap385.18B
AMGEN
AMGN
Mkt Cap160.66B
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Pfizer
PFE
Mkt Cap140.15B
Novartis
NVS
Mkt Cap237.61B
Johnson & Johnson
JNJ
Mkt Cap455.04B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Biogen
BIIB
Mkt Cap22.63B
About
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Show more...
CEO
Dr. Marshall W. Fordyce M.D.
Employees
152
Country
US
ISIN
US92337R1014
Listings
0 Comments
Share your thoughts
FAQ
What is Vera Therapeutics stock price today?▼
The current price of VERA is $40.86 USD — it has increased by +0.89% in the past 24 hours. Watch Vera Therapeutics stock price performance more closely on the chart.
What is Vera Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Vera Therapeutics stocks are traded under the ticker VERA.
Is Vera Therapeutics stock price growing?▼
VERA stock has risen by +5.15% compared to the previous week, the month change is a +3.05% rise, over the last year Vera Therapeutics has showed a +91.74% increase.
What is Vera Therapeutics market cap?▼
Today Vera Therapeutics has the market capitalization of 2.92B
When is the next Vera Therapeutics earnings date?▼
Vera Therapeutics is going to release the next earnings report on May 07, 2026.
What were Vera Therapeutics earnings last quarter?▼
VERA earnings for the last quarter are -1.39 USD per share, whereas the estimation was -1.32 USD resulting in a -4.92% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Vera Therapeutics revenue for the last year?▼
Vera Therapeutics revenue for the last year amounts to 0 USD.
What is Vera Therapeutics net income for the last year?▼
VERA net income for the last year is -599.23M USD.
How many employees does Vera Therapeutics have?▼
As of April 04, 2026, the company has 152 employees.
In which sector is Vera Therapeutics located?▼
Vera Therapeutics operates in the Health Care sector.
When did Vera Therapeutics complete a stock split?▼
Vera Therapeutics has not had any recent stock splits.
Where is Vera Therapeutics headquartered?▼
Vera Therapeutics is headquartered in Brisbane, US.